Announced Mon, 29 Jun · 15:50 IST
Trading Window closed from July 01, 2026 ahead of Q1 results
Compliance View source PDF
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-2.0%1-day move
₹531.00
prior close
₹538.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.7-0.8+0.8-2.0-1.0-5.1-7.7-4.5-0.8-11.9———
Up moveDown movePending
AI summary
Bliss GVS Pharma has closed its trading window from July 01, 2026 until 48 hours after the announcement of unaudited financial results for the quarter ended June 30, 2026. The closure is per SEBI Insider Trading Regulations and applies to insiders, designated persons and their immediate relatives. The board meeting date for the Q1 results will be announced later. This is a routine compliance filing ahead of upcoming earnings.
Likely market impact
Routine compliance filing. No direct stock price impact, but signals that Q1 FY27 earnings announcement is coming in the next few weeks.